CS logo
small CS logo
Institute of Lipid & Atherosclerosis Research

Tel Hashomer, Israel
Medical center in Ramat Gan
Derech Sheba 2, Ramat Gan
1,580 Beds

About Institute of Lipid & Atherosclerosis Research


Chaim Sheba Medical Center at Tel HaShomer, also Tel HaShomer Hospital, is the largest hospital in Israel, located in the Tel Aviv District city of Ramat Gan at Tel HaShomer neighborhood, Israel. In 2020, Newsweek ranked it as the 9th-best hospital in the world.
There are 1,580 beds in Institute of Lipid & Atherosclerosis Research.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Institute of Lipid & Atherosclerosis Research


During the past decade, Institute of Lipid & Atherosclerosis Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Institute of Lipid & Atherosclerosis Research


According to Clinical.Site data, the most researched conditions in "Institute of Lipid & Atherosclerosis Research" are "Dyslipidemia" (2 trials), "Hypercholesterolemia" (2 trials), "Atherosclerosis" (1 trials), "Cerebrotendinous Xanthomatosis (CTX)" (1 trials) and "Dyslipidemias" (1 trials). Many other conditions were trialed in "Institute of Lipid & Atherosclerosis Research" in a lesser frequency.

Clinical Trials Intervention Types at Institute of Lipid & Atherosclerosis Research


Most popular intervention types in "Institute of Lipid & Atherosclerosis Research" are "Drug" (3 trials), "Biological" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Pitavastatin" (3 trials), "Alga Dunaliella Bardawil placebo" (1 trials), "Atorvastatin" (1 trials), "Blood tests" (1 trials) and "Dunaliella Bardawil" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Institute of Lipid & Atherosclerosis Research


The vast majority of trials in "Institute of Lipid & Atherosclerosis Research" are 7 trials for "All" genders.

Clinical Trials Status at Institute of Lipid & Atherosclerosis Research


Currently, there are NaN active trials in "Institute of Lipid & Atherosclerosis Research". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Institute of Lipid & Atherosclerosis Research, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Institute of Lipid & Atherosclerosis Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".